Multiple myeloma starts in the plasma cells inside your bone marrow. People with multiple myeloma have high levels of certain ...

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

But after a seemingly random finger fracture, his doctor tested him for elevated protein levels in his blood and told him he had a form of cancer called multiple myeloma. It was sort of an out-of ...

leading to the overproduction of abnormal proteins that can cause damage to bones, kidneys, and the immune system. 2 Today, treatment for multiple myeloma often involves an intensive combination ...

The modified cells recognise and bind to B-cell maturation antigen (BCMA), a protein that is nearly universally expressed on cancer cells in multiple myeloma, leading to the death of cells ...

The research team envisions sicXer and boXer as components of a novel combined systemic and local treatment strategy for multiple myeloma. Beyond oncology, these materials may have applications in ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

New innovative local treatment for osteolytic bone disease in multiple myeloma. ScienceDaily . Retrieved February 3, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250114125014.htm ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with ...

A Coromandel police officer who narrowly escaped death on the front line has been diagnosed with blood cancer and is now ...

for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior line of therapy, including lenalidomide and a proteasome inhibitor. This approval is based on ...